Eliapixant(1948229-21-7)名称与标识符
名称
英文别名：
Eliapixant;9GH7E6347B;Eliapixant [INN];Eliapixant [USAN];BDBM319844;US10174016, Example 11;WHO 11269;BAY 1817080;3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-oxolan-3-yl]oxy-N-[(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]benzamide;3-(5-Methyl-1,3-thiazol-2-yl)-5-[(3R)-tetrahydrofuran-3-yloxy]-N-{(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}benzamide;GTPL11969;BAY1817080;3-(5-METHYLTHIAZOL-2-YL)-5-((3R)-TETRAHYDROFURAN-3-YL)OXY-N-((1R)-1-(2-(TRIFLUOROMETHYL)PYRIMIDIN-5-YL)ETHYL)BENZAMIDE;3-(5-methylthiazol-2-yl)-5-(((R)-tetrahydrofuran-3-yl)oxy)-N-((R)-1-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)benzamide;P2X Purinoceptor 3 Antagonist BAY 1817080;Eliapixant (USAN/INN);EX-A5494;P2X3 Receptor Antagonist BAY 1817080;BENZAMIDE, 3-(5-METHYL-2-THIAZOLYL)-5-(((3R)-TETRAHYDRO-3-FURANYL)OXY)-N-((1R)-1-(2-(TRIFLUOROMETHYL)-5-PYRIMIDINYL)ETHYL)-;1948229-21-7;D12323;P2X Ligand-gated Ion Channel 3 Receptor Antagonist BAY 1817080;GTQPEQGDLVSFJO-CXAGYDPISA-N;G18011;P2RX3 Antagonist BAY 1817080;CS-0116356;AKOS040759846;MS-28883;3-(5-methyl-1,3-thiazol-2-yl)-5-((3R)-oxolan-3-yl)oxy-N-((1R)-1-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)benzamide;SCHEMBL17823984;UNII-9GH7E6347B;BAY-1817080;HY-109170;DA-52858;CHEMBL5095224;Eliapixant [USAN:INN];
标识符
InChIKey：
GTQPEQGDLVSFJO-CXAGYDPISA-N
Inchi：
1S/C22H21F3N4O3S/c1-12-8-26-20(33-12)15-5-14(6-18(7-15)32-17-3-4-31-11-17)19(30)29-13(2)16-9-27-21(28-10-16)22(23,24)25/h5-10,13,17H,3-4,11H2,1-2H3,(H,29,30)/t13-,17-/m1/s1
SMILES：
S1C(C([H])([H])[H])=C([H])N=C1C1=C([H])C(C(N([H])[C@]([H])(C([H])([H])[H])C2=C([H])N=C(C(F)(F)F)N=C2[H])=O)=C([H])C(=C1[H])O[C@@]1([H])C([H])([H])OC([H])([H])C1([H])[H]
2881489226 
